Trial Profile
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Actual Use Study of the Safety and Tolerability of Gabapentin 500 mg in a Potential OTC Population
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 04 Feb 2021
Price :
$35
*
At a glance
- Drugs Gabapentin (Primary)
- Indications Insomnia
- Focus Adverse reactions
- Sponsors Pfizer
- 05 May 2008 New trial record.